Show simple item record

dc.contributor.authorTaylor, Sally
dc.contributor.authorTsim, S
dc.contributor.authorNavani, N
dc.contributor.authorBaldwin, D
dc.contributor.authorWoolhouse, I
dc.contributor.authorEdwards, J
dc.contributor.authorGrundy, S
dc.contributor.authorRobson, J
dc.contributor.authorRhodes, S
dc.contributor.authorBurnside, N
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorYorke, Janelle
dc.contributor.authorEvison, M
dc.date.accessioned2022-05-04T08:42:01Z
dc.date.available2022-05-04T08:42:01Z
dc.date.issued2021-07
dc.identifier.citationTaylor, Sally, Tsim, S ,Navani, N, Baldwin, D, Woolhouse, I, Edwards, J, Grundy, S, Robson, J, Rhodes, S Burnside, N, Blackhall, Fiona H,Faivre-Finn, Corinne, Yorke, Janelle, Evison, M. Impact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial) Lung Cancer. 2022 Jul; 8(1): e000846.en_US
dc.identifier.pmid34266853
dc.identifier.doi10.1136/bmjresp-2020-000846
dc.identifier.urihttp://hdl.handle.net/10541/625194
dc.language.isoenen_US
dc.relation.urlhttps://dx.doi.org/10.1136/bmjresp-2020-000846en_US
dc.titleImpact on quality of life from multi-modality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multi-modality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)en_US
dc.typeArticleen_US
dc.contributor.departmentChristie Patient Centred Research, The Christie NHS Foundation Trust, Manchester, UKen_US
dc.identifier.journalLung Canceren_US


This item appears in the following Collection(s)

Show simple item record